Rifampicin-induced CYP3A4 activation in CTX patients cannot replace chenodeoxycholic acid treatment.
暂无分享，去创建一个
D. Harats | V. Meiner | P. Gershkovich | A. Shaish | A. Hoffman | M. Gotkine | E. Leitersdorf | Y. Liberman | A. Ben-Ari | A. Szalat | Eti Boutboul